" angioneogenesis" . " cryo-preservation" . "NR8768" . "2011-04-27+02:00"^^ . "1"^^ . . . "2"^^ . . . "Difference in the behaviour of the freshly isolated and cryo-preserved ovarian cancer cells and its clinical significance"@en . " tissue culture" . . . "0"^^ . "http://www.isvav.cz/projectDetail.do?rowId=NR8768"^^ . . . "2006-01-01+01:00"^^ . . . " chemoresistance" . "2008-12-31+01:00"^^ . "ovarian cancer; tissue culture; cryo-preservation; chemoresistance; angioneogenesis; MTT assay"@en . "ovarian cancer" . "Zji\u0161t\u011Bn\u00ED rozd\u00EDl\u016F chov\u00E1n\u00ED (morfologie, motility, prolifera\u010Dn\u00ED aktivity, rezistence) \u010Derstv\u011B izolovan\u00FDch a zmrazen\u00FDch bun\u011Bk ovari\u00E1ln\u00EDch karcinom\u016F a jej\u00ED v\u00FDznam pro klinickou praxi. Vytvo\u0159en\u00ED tk\u00E1\u0148ov\u00E9 banky ovari\u00E1ln\u00ED n\u00E1dorov\u00E9 tk\u00E1n\u011B a s\u00E9ra pacientek s ovari\u00E1ln\u00EDm karcinomem ve Fakultn\u00ED nemocnici v Hradci Kr\u00E1lov\u00E9. Klinick\u00FD v\u00FDznam stanoven\u00ED chemorezistence/chemosensitivity ovari\u00E1ln\u00EDch karcinom\u016F p\u0159ed zah\u00E1jen\u00EDm chemoterapie prvn\u00ED linie. Testov\u00E1n\u00ED prim\u00E1rn\u00ED event. sekund\u00E1rn\u00ED rezistence u \u010Derstv\u011B izolovan\u00FDch a zmrazen\u00FDch bun\u011Bk. Vyu\u017Eit\u00ED marker\u016F angiogeneze (VEGF, CD105) k prognostick\u00FDm \u00FA\u010Del\u016Fm a monitorov\u00E1n\u00ED l\u00E9\u010Dby." . . "2008-03-05+01:00"^^ . "Klinick\u00FD v\u00FDznam rozd\u00EDlu chov\u00E1n\u00ED \u010Derstv\u011B izolovan\u00FDch a zmrazen\u00FDch ovari\u00E1ln\u00EDch n\u00E1dorov\u00FDch bun\u011Bk" . "6"^^ . "6"^^ . "Determination of difference in the behaviour (morphology, motility, proliferation activity) of the freshly isolated and cryo-preserved ovarian cancer cells and its clinical significance. The establishment of Tissue and Serum Biobank in the University Hospital Hradec Kr\u00E1lov\u00E9. The tissues and serum ovarian cancer patients will be stored there. Clinical significance of ovarian cancer chemoresistance/chemosensitivity assay before the beginning of the first line chemotherapy. The comparison of the freshly isolated and cryo-preserved cells. Investigation of angioneogenesis markers in ovarian cancer cells and serum (VEGF,CD105) in relation to clinical state of the patients."@en . "V\u00FDsledky \u0159e\u0161en\u00ED projektu spl\u0148uj\u00ED anotovan\u00E9 c\u00EDle a jsou prvn\u00EDm krokem k dal\u0161\u00EDmu zdokonalov\u00E1n\u00ED testov\u00E1n\u00ED chemosenzitivity a chemorezistence ovari\u00E1ln\u00EDch n\u00E1dorov\u00FDch tk\u00E1n\u00ED tak, aby mohlo b\u00FDt uvedeno do b\u011B\u017En\u00E9 klinick\u00E9 praxe."@cs . . . "The results of the project fulfill its original aims. They represent the first step to improve chemorezistence/ chemosenzitivity test of ovarian tumour tissue to enable its use in clinical practice."@en . . . . . .